NEW YORK (GenomeWeb News) – A federal judge has ordered Illumina to pay $115.1 million to Syntrix Biosystems for infringing a patent held by Syntrix Biosystems.

In his decision handed down on Wednesday, Judge Benjamin Settle, US District Court Western District of Washington, ordered Illumina to pay $96 million in damages that a verdict originally slapped on Illumina in March after finding the San Diego company guilty of infringing US Patent No. 6,951,682 held by Syntrix.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.